Europe — EMA
Olanzapine Accord
Olanzapine, the active ingredient in Olanzapine Accord, is an atypical antipsychotic presented as a tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapine Accord, is an atypical antipsychotic presented as a tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olanzapine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olanzapine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapine Accord is an atypical antipsychotic that modulates neurotransmission in several psychiatric disorders.
- Schizophrenia: helps ‑ reduces positive and negative symptoms and lowers relapse risk. - Bipolar I disorder (manic episodes): helps ‑ controls acute mania and aids maintenance therapy. - Schizoaffective disorder: helps - alleviates psychotic and mood symptoms. - Psychotic depression ‑ adjunct ‑ enhances ‑ response to antidepressant t t
